Skip to main content

Table 5 Characteristics of patient-created AVF with and without early VA failure

From: Factors associated with early failure of vascular access in acute-phase patients

Parameter Without failure (n = 296) With failure (n = 35) P value
Age (years) 66.4 ± 15.0 67.8 ± 17.1 0.5903
Male (%) 68.2 57.1 0.1864
Diabetes (%) 45.6 48.6 0.7393
Hypertension (%) 70.6 71.4 0.9197
Atrial fibrillation (%) 8.5 11.4 0.5551
Primary cause of admission
 Exacerbation of CRF (%) 65.9 62.9 0.7221
 Heart disease (%) 13.9 14.3 0.9440
 Heart failure (%) 10.5 14.3 0.4933
 Coronary artery disease (%) 2.0 0.0 0.3953
 Infectious disease (%) 5.4 8.6 0.4464
 Malignancy (%) 4.1 5.7 0.6444
 Cephalopathy (%) 3.0 2.9 0.9522
 Cerebral infarction (%) 0.7 2.9 0.1978
 Intracranial hemorrhage (%) 1.0 0.0 0.5496
 Peripheral artery disease (%) 0.7 2.9 0.1978
 Aortic disease (%) 1.4 0.0 0.4890
 Others (%) 5.7 2.9 0.4764
Warfarin (%) 10.5 11.4 0.8620
Antiplatelet agent (%) 27.0 22.9 0.5975
Statin (%) 32.4 22.9 0.2485
ACEi or ARB (%) 49.0 45.7 0.7142
Beta blocker (%) 33.1 25.7 0.3765
CCB (%) 63.5 71.4 0.3552
LVEF (%) 56.0 ± 12.5 56.8 ± 13.3 0.7316
SBP (mmHg) 138.9 ± 24.7 132.6 ± 23.4 0.1568
DBP (mmHg) 75.5 ± 16.6 71.1 ± 14.5 0.1309
WBC (103/μL) 7.2 ± 3.2 8.4 ± 3.6 0.0376*
Hb (g/dL) 9.7 ± 1.8 9.7 ± 1.7 0.8780
PLT (104/μL) 19.2 ± 8.1 21.2 ± 8.9 0.1666
TP (g/dL) 6.1 ± 0.9 5.8 ± 0.9 0.0540
ALB (g/dL) 3.1 ± 0.6 2.6 ± 0.7 0.0006**
BUN (mg/dL) 70.1 ± 29.2 60.2 ± 27.8 0.0578
Cr (mg/dL) 7.6 ± 3.0 6.9 ± 2.6 0.1933
eGFR (mL/min/1.7 m2) 7.1 ± 3.8 7.4 ± 3.5 0.6445
AST (IU/L) 22.6 ± 20.3 21.9 ± 12.0 0.8438
ALT (IU/L) 18.6 ± 20.9 15.6 ± 15.9 0.4238
CRP (mg/dL) 2.3 ± 3.4 2.7 ± 4.6 0.5259
APTT 30.7 ± 14.2 28.7 ± 4.7 0.4961
PT-INR 1.17 ± 0.42 1.14 ± 0.25 0.6554
  1. VA vascular access, CRF chronic renal failure, ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker, LVEF left ventricular ejection fraction, SBP systolic blood pressure, DBP diastolic blood pressure, WBC white blood cell, Hb hemoglobin, PLT platelet, TP total protein, ALB albumin, BUN blood urea nitrogen, Cr creatinine, eGFR estimated glomerular filtration rate, AST aspartate aminotransferase, ALT Alanine transaminase, CRP C-reactive protein, APTT activated partial thromboplastin time, PT-INR international normalized ratio of prothrombin time
  2. *P < 0.05; **P < 0.01